Condition: Atrial Fibrillation · Sponsor: Northwell Health
The study aims to evaluate the following: 1) the incidence of new onset atrial fibrillation in patients with an atrial leadless pacemaker, 2) the need for upgrade from a standalone atrial leadless pacemaker to a dual chamber leadless pacemaker system, and 3) to compare the battery longevity of the Aveir AR at two years with the battery longevity of subjects implanted with dual chamber leadless pacemakers in the Aveir DR i2i study.
This description comes directly from the study's public registry record.
Salome Elia Reddy · 516-881-7067 · seliareddy@northwell.edu
Always discuss trial participation with your own doctor first.
| South Shore University Hospital | Bay Shore, New York, United States | Recruiting |
| Huntington Hospital | Huntington, New York, United States | Recruiting |
| North Shore University Hospital | Manhasset, New York, United States | Recruiting |
| Long Island Jewish Medical Center | New Hyde Park, New York, United States | Recruiting |
| Lenox Hill Hospital | New York, New York, United States | Recruiting |
| Staten Island University Hospital | Staten Island, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07638995